Sign In
Buy DXCM
$72.59
-0.180 (-0.247%)
At Close: Jun 04, 2026
DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit with the Schall Law Firm
08:45am, Wednesday, 04'th Sep 2024
LOS ANGELES , Sept. 4, 2024 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against DexCom, Inc. ("DexCom" or "the Com
NEW YORK, NY / ACCESSWIRE / September 4, 2024 / If you suffered a loss on your DexCom, Inc. (NASDAQ:DXCM) investment and want to learn about a potential recovery under the federal securities laws, fol
NEW YORK CITY, NY / ACCESSWIRE / September 4, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against DexCom,
NEW YORK, NY / ACCESSWIRE / September 4, 2024 / If you suffered a loss on your DexCom, Inc. (NASDAQ:DXCM) investment and want to learn about a potential recovery under the federal securities laws, fol
Dexcom to Showcase Transformational Impact of Dexcom CGM Technology at the EASD 2024 Conference Symposium
04:00am, Wednesday, 04'th Sep 2024
EDINBURGH, Scotland--(BUSINESS WIRE)--DexCom, Inc. (Nasdaq: DXCM), a global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, will spotlight the significant benefits of
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of DexCom, Inc.(DXCM) Shareholders
08:45pm, Tuesday, 03'rd Sep 2024
NEW YORK, NY / ACCESSWIRE / September 3, 2024 / If you suffered a loss on your DexCom, Inc. (NASDAQ:DXCM) investment and want to learn about a potential recovery under the federal securities laws, fol
Levi & Korsinsky Notifies DexCom, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline – DXCM
07:00pm, Tuesday, 03'rd Sep 2024
NEW YORK, NY / ACCESSWIRE / September 3, 2024 / If you suffered a loss on your DexCom, Inc. (NASDAQ:DXCM) investment and want to learn about a potential recovery under the federal securities laws, fol
Shareholders that lost money on DexCom, Inc.(DXCM) should contact Levi & Korsinsky about pending Class Action - DXCM
05:45pm, Tuesday, 03'rd Sep 2024
NEW YORK, NY / ACCESSWIRE / September 3, 2024 / If you suffered a loss on your DexCom, Inc. (NASDAQ:DXCM) investment and want to learn about a potential recovery under the federal securities laws, fol
DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit
04:46pm, Tuesday, 03'rd Sep 2024
LOS ANGELES , Sept. 3, 2024 /PRNewswire/ -- The Law Offices of Frank R.
Shareholders of DexCom, Inc. Should Contact Levi & Korsinsky Before October 21, 2024 to Discuss Your Rights – DXCM
04:30pm, Tuesday, 03'rd Sep 2024
NEW YORK, NY / ACCESSWIRE / September 3, 2024 / If you suffered a loss on your DexCom, Inc. (NASDAQ:DXCM) investment and want to learn about a potential recovery under the federal securities laws, fol
NEW YORK, NY / ACCESSWIRE / September 3, 2024 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against DexCom, Inc. (NASDAQ:DXCM) and certain of the Com
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against DexCom, Inc. - DXCM
03:36pm, Tuesday, 03'rd Sep 2024
NEW YORK , Sept. 3, 2024 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against DexCom, Inc. ("DexCom" or the "Company") (NASDAQ: DXCM).
Shareholders of DexCom, Inc. Should Contact Levi & Korsinsky Before October 21, 2024 to Discuss Your Rights - DXCM
02:30pm, Tuesday, 03'rd Sep 2024
NEW YORK, NY / ACCESSWIRE / September 3, 2024 / If you suffered a loss on your DexCom, Inc. (NASDAQ:DXCM) investment and want to learn about a potential recovery under the federal securities laws, fol
DexCom (DXCM) Faces Investor and Analyst Backlash After Revealing Disappointing Growth - Hagens Berman
02:00pm, Tuesday, 03'rd Sep 2024
DXCM Investors with Losses Encouraged to Contact the Firm SAN FRANCISCO, CA / ACCESSWIRE / September 3, 2024 / Hagens Berman urges DexCom, Inc. (NASDAQ:DXCM) investors who suffered substantial losses
DexCom Is the Best Performing Stock in the Nasdaq 100 Tuesday
12:40pm, Tuesday, 03'rd Sep 2024
DexCom stock has fallen 41% this year, but investor sentiment for the maker of glucose monitoring devices could be changing.
